Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more ...

Lawsuit alleges anti-competitive conduct designed to suppress lawful compounding pharmaceuticals and limit patient choice ...

Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Add Yahoo as a preferred source to see more of our stories on Google. A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, the FDA announced that all doses of Novo Nordisk’s Ozempic and Wegovy ...

New Mesa campus deepens Strive’s roots in Arizona, expands production capabilities, and accelerates job creation as the company surpasses 700,000 sq. ft. of national operations. MESA, AZ / ACCESS ...

Empower Pharmacy markets itself as a well-meaning rival to Big Pharma - one that seeks to democratize medicine by making affordable, personalized drugs for patients who need them. As one of an ...